OBJECTIVE: To describe the development of young boys with fragile X syndrome (FXS). METHODS: Fifty-five boys (aged 8-48 months at study entry) with the full mutation FXS received multiple developmental assessments. RESULTS: As expected, the boys' rate of development was significantly lower than chronological age expectations. No evidence of slowing in the rate of development was found. Autistic behavior was negatively associated with development, but maternal IQ was not. Developmental delays were evident in some domains as early as 9 months; however, initial detection of delays is complicated by measures and criteria used. Developmental age scores at 31 months of age were related to scores obtained at 61 months of age only in the global composite and visual reception domain. CONCLUSIONS: Developmental delays are evident in some infants with FXS as young as 9 months of age. Pediatric psychologists need to be informed about the developmental profiles in young children with FXS to accurately diagnose, treat, and support these children and their families.
OBJECTIVE: To describe the development of young boys with fragile X syndrome (FXS). METHODS: Fifty-five boys (aged 8-48 months at study entry) with the full mutation FXS received multiple developmental assessments. RESULTS: As expected, the boys' rate of development was significantly lower than chronological age expectations. No evidence of slowing in the rate of development was found. Autistic behavior was negatively associated with development, but maternal IQ was not. Developmental delays were evident in some domains as early as 9 months; however, initial detection of delays is complicated by measures and criteria used. Developmental age scores at 31 months of age were related to scores obtained at 61 months of age only in the global composite and visual reception domain. CONCLUSIONS: Developmental delays are evident in some infants with FXS as young as 9 months of age. Pediatric psychologists need to be informed about the developmental profiles in young children with FXS to accurately diagnose, treat, and support these children and their families.
Authors: Jennifer Dyer-Friedman; Bronwyn Glaser; David Hessl; Cindy Johnston; Lynne C Huffman; Annette Taylor; Jacob Wisbeck; Allan L Reiss Journal: J Am Acad Child Adolesc Psychiatry Date: 2002-03 Impact factor: 8.829
Authors: Walter E Kaufmann; Ranon Cortell; Alice S M Kau; Irena Bukelis; Elaine Tierney; Robert M Gray; Christiane Cox; George T Capone; Pia Stanard Journal: Am J Med Genet A Date: 2004-09-01 Impact factor: 2.802
Authors: R J Hagerman; C E Hull; J F Safanda; I Carpenter; L W Staley; R A O'Connor; C Seydel; M M Mazzocco; K Snow; S N Thibodeau Journal: Am J Med Genet Date: 1994-07-15
Authors: Jennifer K Gentile; Wen-Hann Tan; Lucia T Horowitz; Carlos A Bacino; Steven A Skinner; Rene Barbieri-Welge; Astrid Bauer-Carlin; Arthur L Beaudet; Terry Jo Bichell; Hye-Seung Lee; Trilochan Sahoo; Susan E Waisbren; Lynne M Bird; Sarika U Peters Journal: J Dev Behav Pediatr Date: 2010-09 Impact factor: 2.225
Authors: Laura J Hahn; B Jean Zimmer; Nancy C Brady; Rebecca E Swinburne Romine; Kandace K Fleming Journal: Am J Speech Lang Pathol Date: 2014-05 Impact factor: 2.408
Authors: Katie Belardi; Linda R Watson; Richard A Faldowski; Heather Hazlett; Elizabeth Crais; Grace T Baranek; Cara McComish; Elena Patten; D Kimbrough Oller Journal: J Autism Dev Disord Date: 2017-04
Authors: Elizabeth A Will; Kelly E Caravella; Laura J Hahn; Deborah J Fidler; Jane E Roberts Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2018-02-05 Impact factor: 3.568